Description
What price do we pay for the longer lives modern science can give us? It is a question that has haunted humanity since Mary Shelley's seminal speculative horror novel, Frankenstein. Today, 200 years since Dr. Frankenstein's monster first sprang to life on the page, artists and thinkers continue to grapple with many of the same questions Shelley raised. Stanford bioethicist Karola Kreitmair explores these themes in her new play, Homo Ex Machina, in which a woman agrees to undergo an experimental treatment--the implantation of a neurostimulator in her brain. The results are more than she and her partner bargained for.
Comments